zinostatin and Pleural-Effusion--Malignant

zinostatin has been researched along with Pleural-Effusion--Malignant* in 1 studies

Other Studies

1 other study(ies) available for zinostatin and Pleural-Effusion--Malignant

Article	Year
[A preliminary report on the treatment of pleural carcinomatosis with SMANCS]. Gan to kagaku ryoho. Cancer & chemotherapy, 2001, Volume: 28, Issue:7 To clarify the effect of SMANCS on malignant pleural carcinomatosis, seven patients with malignant pleural effusion were treated with SMANCS administered via an intracavitary route. Five patients showed improvement after one or two injections of SMANCS into the thoracic cavity, although 2 patients needed further therapy with the immunopotentiating agent picibanil (OK-432). No serious adverse effects were observed. This simple therapeutic tactic with SMANCS may be effective in cases of malignant pleural carcinomatosis. Topics: Aged; Antineoplastic Agents; Breast Neoplasms; Colonic Neoplasms; Female; Humans; Lung Neoplasms; Male; Maleic Anhydrides; Middle Aged; Pleural Effusion, Malignant; Polystyrenes; Stomach Neoplasms; Zinostatin	2001

Article

Year

[A preliminary report on the treatment of pleural carcinomatosis with SMANCS].

Gan to kagaku ryoho. Cancer & chemotherapy, 2001, Volume: 28, Issue:7

To clarify the effect of SMANCS on malignant pleural carcinomatosis, seven patients with malignant pleural effusion were treated with SMANCS administered via an intracavitary route. Five patients showed improvement after one or two injections of SMANCS into the thoracic cavity, although 2 patients needed further therapy with the immunopotentiating agent picibanil (OK-432). No serious adverse effects were observed. This simple therapeutic tactic with SMANCS may be effective in cases of malignant pleural carcinomatosis.

Topics: Aged; Antineoplastic Agents; Breast Neoplasms; Colonic Neoplasms; Female; Humans; Lung Neoplasms; Male; Maleic Anhydrides; Middle Aged; Pleural Effusion, Malignant; Polystyrenes; Stomach Neoplasms; Zinostatin

2001